Sweetener and flavor compositions with improved taste profiles are disclosed. Also disclosed are methods of making and methods of using such sweetener and flavor compositions.

Provided herein is a process for increasing the dissolution rate of a sparingly water soluble flavor or taste modifying compound in water comprising: a. mixing the compound and a highly water soluble second compound in a water based solution to form a solution or dispersion of the compound; and b. drying the solution or dispersion to form a solution or solid dispersion of the compound wherein the compound has an increased dissolution rate in water as compared to the compound when dissolved in water alone.

Sweetener and flavor compositions with improved taste profiles are disclosed. Also disclosed are methods of making and methods of using such sweetener and flavor compositions.

Sweetener and flavor compositions with improved taste profiles are disclosed. Also disclosed are methods of making and methods of using such sweetener and flavor compositions.

A method for inducing satiety in a human subject is disclosed, the method providing a satiety-inducing effect by the administration of, or provision of, a food product comprising less than about 15 grams of total protein, and between about 1.0 to about 3.5 grams of total leucine. The leucine is provided by the total protein and a leucine peptide composition comprising bound leucine.

A composition has ornithine, aspartic acid and vitamin B6, and it is used in preparation of hypolipidemic drugs, health-care products, foods or food additives.

The present invention relates to a novel peptide having various physiological activities and use thereof. The novel peptide according to the present invention induces an increase in joint components in chondrocytes, increases the cartilage differentiation of mesenchymal stem cells and the production of extracellular matrix, suppresses an increase in inflammatory cytokines or inflammatory proteins, and can also suppress the differentiation and formation of osteoclasts, and thus can be effectively used as an active ingredient of a pharmaceutical composition for regenerating cartilage or preventing or treating an inflammatory disease or osteoporosis, or a health functional food for ameliorating the symptoms.

The present invention relates to a novel peptide having various physiological activities and use thereof. The novel peptide according to the present invention induces an increase in joint components in chondrocytes, increases the cartilage differentiation of mesenchymal stem cells and the production of extracellular matrix, suppresses an increase in inflammatory cytokines or inflammatory proteins, and can also suppress the differentiation and formation of osteoclasts, and thus can be effectively used as an active ingredient of a pharmaceutical composition for regenerating cartilage or preventing or treating an inflammatory disease or osteoporosis, or a health functional food for ameliorating the symptoms.

Provided is a food composition that comprises a plurality of amino acids or the salts thereof, wherein the plurality of amino acids or the salts thereof comprise about 0.0016-0.6 wt % of glycine or the salt thereof and about 0.00109-1.2 wt % of serine or the salt thereof. Also provided is a method for treating cancer in a subject in need thereof, comprising partly or completely substituting or replacing the normal diet of the subject with the food composition, and optionally administering to the subject a therapeutically effective amount of an anti-PD-1 antibody or an anti-PD-Li antibody.

Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.